Shares of Xylem Inc. (NYSE:XYL) have been given an average recommendation of “Buy” by the sixteen analysts that are presently covering the stock. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $46.75.

A number of equities analysts recently commented on XYL shares. Atlantic Securities raised Xylem from a “neutral” rating to an “overweight” rating and set a $54.00 price objective on the stock in a research note on Monday, August 22nd. Stifel Nicolaus lifted their price objective on Xylem from $47.00 to $48.00 and gave the stock a “hold” rating in a research note on Wednesday, November 2nd. Canaccord Genuity reaffirmed a “hold” rating and issued a $50.00 price objective (up from $45.00) on shares of Xylem in a research note on Tuesday, August 16th. Janney Montgomery Scott raised Xylem from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $50.00 to $52.00 in a research note on Wednesday, November 2nd. Finally, RBC Capital Markets set a $51.00 price objective on Xylem and gave the stock a “buy” rating in a research note on Tuesday, August 16th.

In related news, SVP Claudia S. Toussaint sold 5,300 shares of the company’s stock in a transaction on Friday, November 4th. The stock was sold at an average price of $47.27, for a total transaction of $250,531.00. Following the completion of the sale, the senior vice president now owns 44,033 shares in the company, valued at $2,081,439.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Colin R. Sabol sold 27,473 shares of the company’s stock in a transaction on Thursday, September 8th. The stock was sold at an average price of $50.91, for a total value of $1,398,650.43. Following the sale, the insider now owns 65,530 shares of the company’s stock, valued at approximately $3,336,132.30. The disclosure for this sale can be found here. Insiders own 0.77% of the company’s stock.

Large investors have recently made changes to their positions in the company. Scout Investments Inc. bought a new stake in shares of Xylem during the third quarter valued at about $27,492,000. Price T Rowe Associates Inc. MD increased its stake in shares of Xylem by 0.4% in the third quarter. Price T Rowe Associates Inc. MD now owns 9,831,231 shares of the company’s stock valued at $515,648,000 after buying an additional 40,520 shares during the period. Quantitative Systematic Strategies LLC bought a new stake in shares of Xylem during the third quarter valued at about $548,000. Somerville Kurt F increased its stake in shares of Xylem by 1.6% in the third quarter. Somerville Kurt F now owns 77,688 shares of the company’s stock valued at $4,074,000 after buying an additional 1,200 shares during the period. Finally, Delaney Dennis R increased its stake in shares of Xylem by 5.5% in the third quarter. Delaney Dennis R now owns 6,337 shares of the company’s stock valued at $332,000 after buying an additional 330 shares during the period. Institutional investors and hedge funds own 85.03% of the company’s stock.

Xylem (NYSE:XYL) opened at 53.29 on Wednesday. The firm has a market cap of $9.56 billion, a P/E ratio of 29.57 and a beta of 1.18. The firm’s 50-day moving average price is $49.96 and its 200-day moving average price is $47.50. Xylem has a 52-week low of $31.67 and a 52-week high of $53.96.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, November 1st. The company reported $0.54 EPS for the quarter, topping the Zacks’ consensus estimate of $0.53 by $0.01. The company had revenue of $897 million for the quarter, compared to analyst estimates of $913.53 million. Xylem had a return on equity of 16.38% and a net margin of 8.83%. The firm’s quarterly revenue was down .6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.49 earnings per share. Equities research analysts expect that Xylem will post $2.04 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 7th. Stockholders of record on Wednesday, November 9th will be issued a dividend of $0.1549 per share. The ex-dividend date of this dividend is Monday, November 7th. This represents a $0.62 annualized dividend and a dividend yield of 1.16%. Xylem’s dividend payout ratio is 34.44%.

Xylem Company Profile

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

5 Day Chart for NYSE:XYL

Receive News & Stock Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related stocks with our FREE daily email newsletter.